(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide

C98H89FN28O5 — CID 159294857

IUPAC(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide
SMILESCc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc(-c4cccnc4)cc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccnnc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc4ccccc4c3)n2)c1
InChIInChI=1S/C24H21N5O.C22H19N5O.C18H16FN5O.C17H17N7O.C17H16N6O/c1-16-10-17(2)12-21(11-16)24-27-15-29(28-24)14-22(23(25)30)19-7-5-18(6-8-19)20-4-3-9-26-13-20;1-14-7-15(2)9-17(8-14)22-25-13-27(26-22)12-19(21(23)28)18-10-16-5-3-4-6-20(16)24-11-18;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13;1-11-5-12(2)7-14(6-11)17-19-10-23(22-17)9-15(16(18)24)13-3-4-20-21-8-13/h3-15H,1-2H3,(H2,25,30);3-13H,1-2H3,(H2,23,28);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21);3-10H,1-2H3,(H2,18,24)/b22-14+;19-12+;15-9+;14-8+;15-9+
InChIKeyLAOUQWWYCPENBC-AQGNDXRCSA-N
MW1757.98 g/mol
LogP13.53
Rot. Bonds21

About (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide

(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide (PubChem CID 159294857) has the molecular formula C98H89FN28O5 and a molecular weight of 1757.98 g/mol. Its IUPAC name is (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide.

Molecular Properties

Compound Name(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide
PubChem CID159294857
Molecular FormulaC98H89FN28O5
Molecular Weight1757.98 g/mol
Exact Mass1756.76
IUPAC Name(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide
SMILESCc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc(-c4cccnc4)cc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccnnc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc4ccccc4c3)n2)c1
InChIInChI=1S/C24H21N5O.C22H19N5O.C18H16FN5O.C17H17N7O.C17H16N6O/c1-16-10-17(2)12-21(11-16)24-27-15-29(28-24)14-22(23(25)30)19-7-5-18(6-8-19)20-4-3-9-26-13-20;1-14-7-15(2)9-17(8-14)22-25-13-27(26-22)12-19(21(23)28)18-10-16-5-3-4-6-20(16)24-11-18;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13;1-11-5-12(2)7-14(6-11)17-19-10-23(22-17)9-15(16(18)24)13-3-4-20-21-8-13/h3-15H,1-2H3,(H2,25,30);3-13H,1-2H3,(H2,23,28);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21);3-10H,1-2H3,(H2,18,24)/b22-14+;19-12+;15-9+;14-8+;15-9+
InChIKeyLAOUQWWYCPENBC-AQGNDXRCSA-N
XLogP13.53
TPSA485.25 Ų
H-Bond Donors6
H-Bond Acceptors28
Rotatable Bonds21
Heavy Atoms132
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001757.98
LogP ≤ 513.53
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide?
The IUPAC name of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide (CID 159294857) is (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide.
What is the SMILES notation for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide?
The canonical SMILES for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide is Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccc(-c4cccnc4)cc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cccnc3F)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3ccnnc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc(N)nc3)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C(/C(N)=O)c3cnc4ccccc4c3)n2)c1.
What is the InChIKey of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide?
The InChIKey is LAOUQWWYCPENBC-AQGNDXRCSA-N. The full InChI is InChI=1S/C24H21N5O.C22H19N5O.C18H16FN5O.C17H17N7O.C17H16N6O/c1-16-10-17(2)12-21(11-16)24-27-15-29(28-24)14-22(23(25)30)19-7-5-18(6-8-19)20-4-3-9-26-13-20;1-14-7-15(2)9-17(8-14)22-25-13-27(26-22)12-19(21(23)28)18-10-16-5-3-4-6-20(16)24-11-18;1-11-6-12(2)8-13(7-11)18-22-10-24(23-18)9-15(17(20)25)14-4-3-5-21-16(14)19;1-10-3-11(2)5-12(4-10)16-22-9-24(23-16)8-14(15(18)25)13-6-20-17(19)21-7-13;1-11-5-12(2)7-14(6-11)17-19-10-23(22-17)9-15(16(18)24)13-3-4-20-21-8-13/h3-15H,1-2H3,(H2,25,30);3-13H,1-2H3,(H2,23,28);3-10H,1-2H3,(H2,20,25);3-9H,1-2H3,(H2,18,25)(H2,19,20,21);3-10H,1-2H3,(H2,18,24)/b22-14+;19-12+;15-9+;14-8+;15-9+.
What are the key properties of (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide?
(E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide has a molecular weight of 1757.98 g/mol, XLogP of 13.53, 21 rotatable bonds, 6 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-2-(2-aminopyrimidin-5-yl)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(2-fluoro-3-pyridinyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-pyridazin-4-ylprop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-(4-pyridin-3-ylphenyl)prop-2-enamide;(E)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-2-quinolin-3-ylprop-2-enamide is sourced from PubChem (CID 159294857), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).